Synthace

OverviewSuggest Edit

The UK’s first dedicated synthetic biology company with a world leading platform of technologies for the rapid engineering and optimisation of novel biological production systems. A spin out of University College London, Synthace is already producing high-value research and development products for the pharmaceutical, agrochemical and fine chemicals industry. Synthace bioengineering is enabled by a tight integration of computational modelling and big data analysis with wet lab experimental design and validation, and novel molecular biology tools. While Synthace bioengineering is broadly applicable across multiple industry sectors, the company is focused towards applications in the production of specialty chemicals.
TypePrivate
Founded2011
HQLondon, GB
Websitesynthace.com
Employee Ratings4.7

Latest Updates

Employees (est.) (Jun 2022)75(+2%)
Revenue (FY, 2013)£581
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Synthace

Christopher Grant Ward

Christopher Grant Ward

Co-founder, Head Of Research And Development
Fane Mensah

Fane Mensah

Life Sciences Business Director
Markus Gershater

Markus Gershater

Co-founder, Chief Scientific Officer
Mark Watson

Mark Watson

Chief Commercial Officer
Show more

Synthace Office Locations

Synthace has offices in London and Cambridge
London, GB (HQ)
195 Wood Ln, Shepherd's Bush
Cambridge, MA, US
101 Main St
Show all (2)

Synthace Financials and Metrics

Summary Metrics

Founding Date

2011

Synthace total Funding

$41.8 m

Synthace latest funding size

$25.6 m

Time since last funding

4 years ago

Synthace investors

Synthace's latest funding round in December 2018 was reported to be $25.6 m. In total, Synthace has raised $41.8 m
Show all financial metrics

Synthace Revenue

Synthace's revenue was reported to be £581 in FY, 2013
GBP

Revenue (FY, 2013)

581.0

Net income (FY, 2013)

(361.6k)

EBITDA (FY, 2013)

(356.8k)

EBIT (FY, 2013)

(361.6k)

Cash (31-May-2018)

4.9m
GBPFY, 2012FY, 2013

Revenue

581.0

Operating expense total

362.2k

EBITDA

(356.8k)

EBITDA margin, %

(61413%)
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

351.4k103.4k321.7k1.5m245.0k224.3k4.9m

Accounts Receivable

240.0159.9k73.2k9.6k46.6k107.7k

Current Assets

358.1k150.1k481.6k1.6m646.8k883.2k5.8m

PP&E

1.6k14.8k298.8k200.5k265.6k186.8k235.7k
GBPFY, 2012FY, 2013

Net Income

(43.1k)(361.6k)
GBPFY, 2012

Financial Leverage

1 x
Show all financial metrics

Synthace Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

SecurityScorecard logo

Synthace Online and Social Media Presence

Embed Graph

Synthace News and Updates

Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing

London’s Synthace has raised $35 million in a Series C funding round. The life sciences company provides an R&D cloud platform that gives scientists around the globe the ability to […] The post Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing ap…

Synthace raises $25.6 million to automate bio labs with software

Synthace, a U.K. startup developing an operating system to automate lab work, announced that it has raised $25.6 million in a Series B round.

Synthace reels in $9.6 mln Series A

London-based Synthace, the developer of the Antha operating system for biology, has raised $9.6 million in Series A funding. The investors included White Cloud Capital, Amadeus Capital Partners, Eleven Two Capital, Sofinnova Partners, SOSV and Bioeconomy Capital.

Synthace Blogs

Earth Day 2022: We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It?

Earth Day 2022: We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It? Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Assay Development Automation Biology Bioprocessing Carbon Climate Ch…

How to Make High Throughput Design of Experiments the Norm in Assay Development

How to Make High Throughput Design of Experiments the Norm in Assay Development Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Assay Development Automation Bioprocessing concentration normalization Conference Cus…

UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality

UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing concentration normalization Conference Customer Success Data Demo …

How to Normalize Concentrations in a Fraction of the Time

How to Normalize Concentrations in a Fraction of the Time Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing concentration normalization Conference Customer Success Data Demo Design of Experi…

Too Many Hats: How Biology Drains Biologists

Too Many Hats: How Biology Drains Biologists Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineerin…

How To Get Started With Design of Experiments

How To Get Started With Design of Experiments Filter Search by keyword Browse by category Article Bioprocessing Gene Therapy Lab of the Future News Our People Uncategorised Tags AI Automation Bioprocessing Conference Customer Success Data Demo Design of Experiments (DOE) DNA Assembly ELISA Engineeri…
Show more

Synthace Frequently Asked Questions

  • When was Synthace founded?

    Synthace was founded in 2011.

  • Who are Synthace key executives?

    Synthace's key executives are Christopher Grant Ward, Fane Mensah and Markus Gershater.

  • How many employees does Synthace have?

    Synthace has 75 employees.

  • What is Synthace revenue?

    Latest Synthace annual revenue is £581.

  • What is Synthace revenue per employee?

    Latest Synthace revenue per employee is £8.

  • Who are Synthace competitors?

    Competitors of Synthace include International Stem Cell Corporation, The Biomedical Engineering Society and IDEXX.

  • Where is Synthace headquarters?

    Synthace headquarters is located at 195 Wood Ln, Shepherd's Bush, London.

  • Where are Synthace offices?

    Synthace has offices in London and Cambridge.

  • How many offices does Synthace have?

    Synthace has 2 offices.